tetano
Editor, Senior Moderator
J Clin Lab Anal
. 2021 Nov 6;e24091.
doi: 10.1002/jcla.24091. Online ahead of print.
A rapid lateral flow immunoassay strip for detection of SARS-CoV-2 antigen using latex microspheres
Lin Shen[SUP] 1 [/SUP], Qihan Zhang[SUP] 2 [/SUP], Xiaolu Luo[SUP] 3 [/SUP], Haolin Xiao[SUP] 2 [/SUP], Miao Gu[SUP] 4 [/SUP], Liangli Cao[SUP] 1 [/SUP], Feijun Zhao[SUP] 1 [/SUP], Zhencheng Chen[SUP] 1 2 [/SUP]
Affiliations
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious and concealed virus that causes pneumonia, severe acute respiratory syndrome, and even death. Although the epidemic has been controlled since the development of vaccines and quarantine measures, many people are still infected, particularly in third-world countries. Several methods have been developed for detection of SARS-CoV-2, but owing to its price and efficiency, the immune strip could be a better method for the third-world countries.
Methods: In this study, two antibodies were linked to latex microspheres, using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide, as the bridge to decrease the cost further and improve the detection performance. The specificity of the lateral flow immunoassay strip (LFIA) was tested by several common viruses and respiratory bacterial infections. Besides, the reproducibility and stability of the LFIAs were tested on the same batch of test strips. Under optimal conditions, the sensitivity of LFIA was determined by testing different dilutions of the positive specimens.
Results: The proposed LFIAs were highly specific, and the limit of detection was as low as 25 ng/mL for SARS-CoV-2 antigens. The clinical applicability was evaluated with 659 samples (230 positive and 429 negative samples) by using both LFIA and rRT-PCR. Youden's index (J) was used to assess the performance of these diagnostic tests. The sensitivity and specificity were 98.22% and 97.93%, respectively, and J is 0.9615. The sensitivity and specificity were 98.22% and 97.93%, respectively, and J is 0.9615. In addition, the consistency of our proposed LFIA was analyzed using Cohen's kappa coefficient (κ = 0.9620).
Conclusion: We found disease stage, age, gender, and clinical manifestations have only a slight influence on the diagnosis. Therefore, the lateral flow immunoassay SARS-CoV-2 antigen test strip is suitable for point-of-care detection and provides a great application for SARS-CoV-2 epidemic control in the third-world countries.
Keywords: EDC and NHS; SARS-CoV-2 antigen; latex microspheres.
. 2021 Nov 6;e24091.
doi: 10.1002/jcla.24091. Online ahead of print.
A rapid lateral flow immunoassay strip for detection of SARS-CoV-2 antigen using latex microspheres
Lin Shen[SUP] 1 [/SUP], Qihan Zhang[SUP] 2 [/SUP], Xiaolu Luo[SUP] 3 [/SUP], Haolin Xiao[SUP] 2 [/SUP], Miao Gu[SUP] 4 [/SUP], Liangli Cao[SUP] 1 [/SUP], Feijun Zhao[SUP] 1 [/SUP], Zhencheng Chen[SUP] 1 2 [/SUP]
Affiliations
- PMID: 34741352
- DOI: 10.1002/jcla.24091
Abstract
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious and concealed virus that causes pneumonia, severe acute respiratory syndrome, and even death. Although the epidemic has been controlled since the development of vaccines and quarantine measures, many people are still infected, particularly in third-world countries. Several methods have been developed for detection of SARS-CoV-2, but owing to its price and efficiency, the immune strip could be a better method for the third-world countries.
Methods: In this study, two antibodies were linked to latex microspheres, using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide, as the bridge to decrease the cost further and improve the detection performance. The specificity of the lateral flow immunoassay strip (LFIA) was tested by several common viruses and respiratory bacterial infections. Besides, the reproducibility and stability of the LFIAs were tested on the same batch of test strips. Under optimal conditions, the sensitivity of LFIA was determined by testing different dilutions of the positive specimens.
Results: The proposed LFIAs were highly specific, and the limit of detection was as low as 25 ng/mL for SARS-CoV-2 antigens. The clinical applicability was evaluated with 659 samples (230 positive and 429 negative samples) by using both LFIA and rRT-PCR. Youden's index (J) was used to assess the performance of these diagnostic tests. The sensitivity and specificity were 98.22% and 97.93%, respectively, and J is 0.9615. The sensitivity and specificity were 98.22% and 97.93%, respectively, and J is 0.9615. In addition, the consistency of our proposed LFIA was analyzed using Cohen's kappa coefficient (κ = 0.9620).
Conclusion: We found disease stage, age, gender, and clinical manifestations have only a slight influence on the diagnosis. Therefore, the lateral flow immunoassay SARS-CoV-2 antigen test strip is suitable for point-of-care detection and provides a great application for SARS-CoV-2 epidemic control in the third-world countries.
Keywords: EDC and NHS; SARS-CoV-2 antigen; latex microspheres.